Bionano Genomics Current Deferred Revenue (Quarterly) Insights

Bionano Genomics, Inc. (BNGO)

1.62 -0.05 (-2.99%) USD | NASDAQ | Jan 23, 16:00

1.60 -0.02 (-1.23%) Pre-Market: 20:00

View Current Deferred Revenue (Quarterly) for BNGO.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

Bruker Corp.	Upgrade
Azenta, Inc.	Upgrade
Harvard Bioscience, Inc.	Upgrade
Precipio, Inc.	Upgrade
Kestra Medical Technologies Ltd.	--